Stacey Siese
Nurse Practitioner · Las Vegas, NVNPI 1669092367
Payments from drug & device makers
Across 122 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$218
- Bayer$218
- AstraZeneca$197
- Novo Nordisk$192
- AbbVie$175
- Pfizer$141
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,399100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 13 | $218 |
| Bayer | 11 | $218 |
| AstraZeneca | 10 | $197 |
| Novo Nordisk | 10 | $192 |
| AbbVie | 9 | $175 |
| Pfizer | 7 | $141 |
| Amgen | 6 | $123 |
| Exact Sciences | 6 | $102 |
| Abbott | 4 | $102 |
| Merck | 4 | $80 |
| Astellas Pharma US Inc | 4 | $79 |
| Kowa Pharmaceuticals America, Inc. | 4 | $70 |
| Dexcom, Inc. | 4 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $66 |
| Phadia US Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Sanofi | 2 | $50 |
| Mylan Specialty L.p. | 2 | $48 |
| GSK | 2 | $41 |
| CSL Behring | 1 | $38 |
| Almatica Pharma LLC | 2 | $36 |
| Johnson & Johnson | 2 | $32 |
| Lundbeck LLC | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Boehringer Ingelheim | 1 | $29 |
| Baxter Healthcare | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Boston Scientific | 1 | $20 |
| Novartis | 1 | $17 |
| Optos, Inc. | 1 | $16 |
| Inogen, Inc. | 1 | $16 |
| Corcept Therapeutics | 1 | $13 |
How this compares
$2,399 in reported general payments places this provider in the 85th percentile of 933 nurse practitioner providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 74 | $96,748 |
| OzempicSemaglutide | 71 | $87,241 |
| JanuviaSitagliptin Phosphate | 23 | $30,239 |
| JardianceEmpagliflozin | 23 | $28,946 |
| MounjaroTirzepatide | 22 | $23,249 |
| FarxigaDapagliflozin Propanediol | 21 | $19,108 |
| XareltoRivaroxaban | 20 | $16,851 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $12,418 |
| BrilintaTicagrelor | 13 | $7,289 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $5,636 |
| Atorvastatin Calcium | 469 | $4,403 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $4,105 |
| Gabapentin | 161 | $4,071 |
| Losartan Potassium | 313 | $3,340 |
| Levothyroxine Sodium | 290 | $2,886 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $141 | $96,74874 claims |
| Novo NordiskOzempic | $192 | $87,24171 claims |
| MerckJanuvia | $80 | $30,23923 claims |
| Boehringer IngelheimJardiance | $29 | $28,94623 claims |
| AstraZenecaFarxiga, Brilinta | $197 | $26,39834 claims |
| Lilly USA, LLCMounjaro | $218 | $23,24922 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $41 | $18,05325 claims |
| Johnson & JohnsonXarelto | $32 | $16,85120 claims |
| AbbVieSynthroid | $175 | $2,60930 claims |
| Almatica Pharma LLCSertraline Hcl | $36 | $1,24032 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 933 nurse practitioner providers in Nevada.
Other nurse practitioner in Las Vegas
- Vanessa AntolinLas Vegas$225K
- Shannon SouthwickLas Vegas$85K
- Melanie SpeedLas Vegas$80K
- Shelley MilesLas Vegas$34K
- Nasslynne LenzLas Vegas$32K
- Bonnie KwanLas Vegas$30K
- Amanda RalphLas Vegas$26K
- Teodoro AgtayLas Vegas$25K
- Katherine WhitmireLas Vegas$18K
- Jennifer WalshLas Vegas$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.